Cargando…

Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis

Detalles Bibliográficos
Autores principales: Liang, Yiran, Song, Xiaojin, Li, Yaming, Chen, Bing, Zhao, Wenjing, Wang, Lijuan, Zhang, Hanwen, Liu, Ying, Han, Dianwen, Zhang, Ning, Ma, Tingting, Wang, Yajie, Ye, Fangzhou, Luo, Dan, Li, Xiaoyan, Yang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205067/
https://www.ncbi.nlm.nih.gov/pubmed/35715798
http://dx.doi.org/10.1186/s12943-022-01576-y
_version_ 1784729051351482368
author Liang, Yiran
Song, Xiaojin
Li, Yaming
Chen, Bing
Zhao, Wenjing
Wang, Lijuan
Zhang, Hanwen
Liu, Ying
Han, Dianwen
Zhang, Ning
Ma, Tingting
Wang, Yajie
Ye, Fangzhou
Luo, Dan
Li, Xiaoyan
Yang, Qifeng
author_facet Liang, Yiran
Song, Xiaojin
Li, Yaming
Chen, Bing
Zhao, Wenjing
Wang, Lijuan
Zhang, Hanwen
Liu, Ying
Han, Dianwen
Zhang, Ning
Ma, Tingting
Wang, Yajie
Ye, Fangzhou
Luo, Dan
Li, Xiaoyan
Yang, Qifeng
author_sort Liang, Yiran
collection PubMed
description
format Online
Article
Text
id pubmed-9205067
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92050672022-06-18 Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis Liang, Yiran Song, Xiaojin Li, Yaming Chen, Bing Zhao, Wenjing Wang, Lijuan Zhang, Hanwen Liu, Ying Han, Dianwen Zhang, Ning Ma, Tingting Wang, Yajie Ye, Fangzhou Luo, Dan Li, Xiaoyan Yang, Qifeng Mol Cancer Retraction Note BioMed Central 2022-06-17 /pmc/articles/PMC9205067/ /pubmed/35715798 http://dx.doi.org/10.1186/s12943-022-01576-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Retraction Note
Liang, Yiran
Song, Xiaojin
Li, Yaming
Chen, Bing
Zhao, Wenjing
Wang, Lijuan
Zhang, Hanwen
Liu, Ying
Han, Dianwen
Zhang, Ning
Ma, Tingting
Wang, Yajie
Ye, Fangzhou
Luo, Dan
Li, Xiaoyan
Yang, Qifeng
Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
title Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
title_full Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
title_fullStr Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
title_full_unstemmed Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
title_short Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
title_sort retraction note to: lncrna bcrt1 promotes breast cancer progression by targeting mir-1303/ptbp3 axis
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205067/
https://www.ncbi.nlm.nih.gov/pubmed/35715798
http://dx.doi.org/10.1186/s12943-022-01576-y
work_keys_str_mv AT liangyiran retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT songxiaojin retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT liyaming retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT chenbing retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT zhaowenjing retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT wanglijuan retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT zhanghanwen retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT liuying retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT handianwen retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT zhangning retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT matingting retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT wangyajie retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT yefangzhou retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT luodan retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT lixiaoyan retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis
AT yangqifeng retractionnotetolncrnabcrt1promotesbreastcancerprogressionbytargetingmir1303ptbp3axis